10.1016/j.apsb.2020.06.016 Summary Keywords thonningianin A, Acetaminophen, acute liver injury, GPx4, endoplasmic reticulum stress, hepatotoxicity Citation Lai S, Ye Y, Ding Q, Hu X, Fu A, Wu L, Cao W, Liu Q, Dou X and Qi X (2025) Thonningianin A ameliorates acetaminophen-induced liver injury by activating GPX4 and modulating endoplasmic reticulum stress
Note: CMS's Medicare GLP-1 Bridge (July 2026) may offer ~$50/month access to eligible GLP-1s
Check for the confounders
KFF Health Tracking Poll May 2024: The Publics Use and Views of GLP-1 Drugs Findings Key Findings The latest KFF Health Tracking Poll finds that about one in eight adults (12%) say they have ever taken a GLP-1 agonist an increasingly popular class of prescription drugs used for weight loss and to treat diabetes or prevent heart attacks or strokes for adults with heart disease including 6% who say they are currently taking such a drug
Our programs target both the physical and emotional aspects of weight management, supported by evidence showing 15-20% body weight reduction